Skip to search.
 STI Up 0.95%

Becton, Dickinson and Company (BDX)

-NYSE
166.99 Down 0.20(0.12%) 28 May 04:00 SGT
Prev Close:167.19
Open:167.07
Bid:166.95 x 500
Ask:166.97 x 800
1y Target Est:174.88
Beta:1.01242
Earnings Date:4 Aug - 8 Aug (Est.)
Day's Range:166.40 - 167.38
52wk Range:128.87 - 169.08
Volume:648,605
Avg Vol (3m):994,716
Market Cap:35.44B
P/E (ttm):44.64
EPS (ttm):3.74
Div & Yield:2.64 (1.58%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BDXDown 0.12%35.44B
BAXDown 0.28%23.92B
ABTUp 1.05%57.74B

Key Statistics

Forward P/E (1 yr):17.67
P/S (ttm):2.90
Ex-Dividend Date:08-Mar-16

Analysts

Annual EPS Est (Sep-16) :8.57
Quarterly EPS Est (Jun-16) :2.21
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback